From: Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
Variables
OR (CI)
p-value
Total CTCs (< 3 vs 3 or more)
6.67E+14 (17.4 − ∞)
0.0004
DFS (60 months or more vs < 60)
2.32E+14 (2.78 − ∞)
0.020